Related Experiment Video
Updated: Oct 20, 2025
Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test
Published on: January 15, 2010
Failure of Diphtheria Toxin Model to Induce Parkinson-Like Behavior in Mice
Lucie Valek1, Irmgard Tegeder1
1Institute of Clinical Pharmacology, Medical Faculty, Goethe-University, 60590 Frankfurt, Germany.
Abstract:
Rodent models of Parkinson's disease are based on transgenic expression of mutant synuclein, deletion of PD genes, injections of MPTP or rotenone, or seeding of synuclein fibrils. The models show histopathologic features of PD such as Lewi bodies but mostly only subtle in vivo manifestations or systemic toxicity. The models only partly mimic a predominant loss of dopaminergic neurons in the substantia nigra. We therefore generated mice that express the transgenic diphtheria toxin receptor (DTR) specifically in DA neurons by crossing DAT-Cre mice with Rosa26 loxP-STOP-loxP DTR mice. After defining a well-tolerated DTx dose, DAT-DTR and DTR-flfl controls were subjected to non-toxic DTx treatment (5 × 100 pg/g) and subsequent histology and behavioral tests. DAT protein levels were reduced in the midbrain, and tyrosine hydroxylase-positive neurons were reduced in the substantia nigra, whereas the pan-neuronal marker NeuN was not affected. Despite the promising histologic results, there was no difference in motor function tests or open field behavior. These are tests in which double mutant Pink1-/-SNCAA53T Parkinson mice show behavioral abnormalities. Higher doses of DTx were toxic in both groups. The data suggest that DTx treatment in mice with Cre/loxP-driven DAT-DTR expression leads to partial ablation of DA-neurons but without PD-reminiscent behavioral correlates.
Insights
This study created mice with targeted dopamine neuron loss to model Parkinson's disease (PD). While histology showed neuron loss, the mice did not exhibit PD-related behavioral changes.
Area of Science:
- Neuroscience
- Parkinson's Disease Research
- Animal Models
Background:
- Current Parkinson's disease (PD) rodent models exhibit limitations in fully recapitulating the selective loss of dopaminergic neurons in the substantia nigra.
- Existing models often show subtle in vivo manifestations or systemic toxicity, partly mimicking histopathological features like Lewy bodies.
Purpose of the Study:
- To develop a novel mouse model for Parkinson's disease by selectively ablating dopaminergic (DA) neurons in the substantia nigra.
- To investigate if targeted DA neuron loss in mice using diphtheria toxin (DTx) results in PD-relevant behavioral deficits.
Main Methods:
- Generated transgenic mice expressing the diphtheria toxin receptor (DTR) specifically in DA neurons by crossing DAT-Cre with Rosa26 loxP-STOP-loxP DTR mice.
- Administered a well-tolerated dose of DTx to DAT-DTR mice and controls, followed by histological analysis and behavioral testing.
Main Results:
- DTx treatment resulted in reduced DAT protein levels in the midbrain and a decrease in tyrosine hydroxylase-positive neurons in the substantia nigra.
- Despite histological evidence of DA neuron loss, DAT-DTR mice did not show significant differences in motor function or open field behavior compared to controls.
- Higher DTx doses induced systemic toxicity in both experimental and control groups.
Conclusions:
- Targeted DTx administration in DAT-DTR mice achieves partial ablation of DA neurons, validating the model's histological aspect.
- The developed model, at the tested DTx dose, does not replicate the behavioral phenotype observed in other PD mouse models, suggesting a dissociation between DA neuron loss and motor deficits.
